Ensign Peak Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.04M | Buy |
68,468
+230
| +0.3% | +$13.6K | 0.01% | 688 |
|
|
2025
Q1 | $5M | Buy |
68,238
+7,591
| +13% | +$556K | 0.01% | 635 |
|
|
2024
Q4 | $5.02M | Buy |
60,647
+24,289
| +67% | +$2.01M | 0.01% | 646 |
|
|
2024
Q3 | $2.6M | Hold |
36,358
| – | – | ﹤0.01% | 838 |
|
|
2024
Q2 | $2.49M | Hold |
36,358
| – | – | ﹤0.01% | 827 |
|
|
2024
Q1 | $1.95M | Buy |
36,358
+4,366
| +14% | +$234K | ﹤0.01% | 935 |
|
|
2023
Q4 | $1.7M | Buy |
31,992
+10,700
| +50% | +$570K | ﹤0.01% | 993 |
|
|
2023
Q3 | $1.06M | Hold |
21,292
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q2 | $1.27M | Hold |
21,292
| – | – | ﹤0.01% | 1079 |
|
|
2023
Q1 | $1.21M | Hold |
21,292
| – | – | ﹤0.01% | 1092 |
|
|
2022
Q4 | $1.58M | Sell |
21,292
-5,300
| -20% | -$394K | ﹤0.01% | 900 |
|
|
2022
Q3 | $1.58M | Sell |
26,592
-420
| -2% | -$25K | ﹤0.01% | 862 |
|
|
2022
Q2 | $1.52M | Hold |
27,012
| – | – | ﹤0.01% | 929 |
|
|
2022
Q1 | $1.99M | Sell |
27,012
-1,855
| -6% | -$137K | ﹤0.01% | 890 |
|
|
2021
Q4 | $2.08M | Sell |
28,867
-43,325
| -60% | -$3.13M | ﹤0.01% | 937 |
|
|
2021
Q3 | $5.53M | Buy |
72,192
+5,500
| +8% | +$421K | 0.01% | 613 |
|
|
2021
Q2 | $5.17M | Buy |
66,692
+3,335
| +5% | +$259K | 0.01% | 638 |
|
|
2021
Q1 | $3.91M | Sell |
63,357
-16,015
| -20% | -$988K | 0.01% | 735 |
|
|
2020
Q4 | $5.18M | Sell |
79,372
-1,160
| -1% | -$75.7K | 0.01% | 598 |
|
|
2020
Q3 | $3.99M | Hold |
80,532
| – | – | 0.01% | 694 |
|
|
2020
Q2 | $3.84M | Hold |
80,532
| – | – | 0.01% | 695 |
|
|
2020
Q1 | $3.43M | Buy |
80,532
+23,310
| +41% | +$991K | 0.01% | 619 |
|
|
2019
Q4 | $3.37M | Buy |
+57,222
| New | +$3.37M | 0.01% | 787 |
|